The University of Tokyo · Medicine
Professor Toshio Kitamura's research lab focuses on the molecular mechanisms underlying hematopoiesis and myeloid malignancies, with a particular emphasis on cytokine signaling, transcription factors such as STAT5, and epigenetic regulators like ASXL1. The lab investigates how cytokine receptors, including those for GM-CSF and IL-3, mediate hematopoietic cell growth and differentiation, and how mutations in key regulators such as ASXL1 contribute to clonal hematopoiesis and leukemia pathogenesis. Using advanced genetic and molecular tools, including retroviral expression systems and conditional knock-in models, the lab uncovers the functional consequences of oncogenic signaling and epigenetic alterations in hematopoietic stem cells. Their work bridges basic signaling mechanisms with translational insights into blood disorders and cancer.
Figures are computed from collected data and may differ slightly.
We have established a novel cell line, designated as TF-1, from a patient with erythroleukemia, which showed complete growth dependency on granulocyte-macrophage colony-stimulating factor (GM-CSF) or on interleukin-3 (IL-3) and carried a homogeneous chromosomal abnormality (54X). Erythropoietin (EPO) also sustained the short-term growth of TF-1, but did not induce erythroid differentiation. These three hematopoietic growth factors acted on TF-1 synergistically. Transforming growth factor-beta an
STAT (signal transducers and activators of transcription) proteins are transcription factors which are activated by phosphorylation on tyrosine residues upon stimulation by cytokines. Seven members of the STAT family are known, including the closely related STAT5A and STAT5B, which are activated by various cytokines. Except for prolactin-dependent beta-casein production in mammary gland cells, the biological consequences of STAT5 activation in various systems are not clear. We applied PCR-driven
The high-affinity receptor for human granulocyte/macrophage colony-stimulating factor (hGM-CSF) is composed of two subunits, alpha and beta. The alpha subunit binds GM-CSF with low affinity, whereas the beta subunit does not bind GM-CSF by itself. The alpha and beta subunits together form the high-affinity GM-CSF receptor. The beta subunit has extensive sequence homology with the mouse interleukin 3 (IL-3) receptor (AIC2A) and its homologue (AIC2B) that does not bind IL-3 or other cytokines incl
Additional sex combs like 1 (ASXL1) is frequently mutated in myeloid malignancies and clonal hematopoiesis of indeterminate potential (CHIP). Although loss of ASXL1 promotes hematopoietic transformation, there is growing evidence that ASXL1 mutations might confer an alteration of function. In this study, we identify that physiological expression of a C-terminal truncated Asxl1 mutant in vivo using conditional knock-in (KI) results in myeloid skewing, age-dependent anemia, thrombocytosis, and mor
Open papers in the app to read, cite, and organize with AI.
